--- title: "China's BrainCo turned a focus-tracking EEG headband into a 100,000-unit product — and a pre-IPO unicorn" date: 2026-09-28 category: Brain–Computer Interface site: NeuroAI canonical: https://neuroai.site/a/na-bci-consumer-focus-headset language: en --- # China's BrainCo turned a focus-tracking EEG headband into a 100,000-unit product — and a pre-IPO unicorn > BrainCo (强脑科技), a Hangzhou neurotechnology company born in a Harvard lab, is one of the few brain–computer interface (脑机接口) firms with a consumer product that actually shipped at scale. Its Focus EEG headband line crossed 100,000 units in mass production, and in January 2026 the company closed a roughly 2 billion RMB round and filed confidentially for a Hong Kong IPO. A child in a Chinese classroom puts on a soft band with a few sensors, and a teacher's screen lights up with a number: how focused is this student, right now, according to their brainwaves? A few years ago that scene sparked a privacy outcry. Today the same company behind it is preparing to list on the Hong Kong stock exchange. BrainCo (强脑科技) is not a lab experiment. It is one of the rare brain–computer interface (脑机接口) companies that crossed from prototype to factory floor — and then to a capital-markets queue. ## From a Harvard basement to Hangzhou BrainCo was founded in **2015** by **Bicheng Han (韩璧丞)**, then a PhD candidate at Harvard University's Center for Brain Science, and was incubated at the Harvard Innovation Labs. In **2018** the company moved its headquarters to Hangzhou, Zhejiang, while keeping a US office in Somerville, Massachusetts. Its bet was on **non-invasive BCI** — reading brain signals through the scalp with EEG (electroencephalography) rather than implanting electrodes. That choice trades signal richness for safety and scalability, and it is what made a consumer product possible. ## The headband that actually shipped The flagship consumer line is **Focus**, an EEG headband that measures attention and, in later versions, helps with relaxation and sleep. The first version, **Focus 1**, was shown in 2016; it was later rebranded toward wellness as **FocusCalm** and **FocusZen (正念舒压)**. The milestone that separates BrainCo from most BCI startups is volume. In **January 2022**, the company held a ceremony for the **100,000th unit** of its second-generation wearable EEG device rolling off the line — reported by *China Daily* as the world's first high-precision BCI product to reach six-figure mass production. BrainCo describes that as proof the engineering problems of portable, low-noise bio-signal capture had been solved well enough to sell. The headband has shown up in three very different places: - **Classrooms** in China, as "Focus EDU," where teachers tracked group attention — a use that drew criticism in 2019 over student surveillance and was reportedly pulled from school trials. - **Elite sports**, where athletes used EEG feedback to train focus and manage stress. - **Wellness and sleep**, through spin-off products like **Easleep** and the meditation system **Zentopia**. ## The money and the listing BrainCo is frequently called **China's first BCI unicorn**. In **January 2026** it closed a financing round of roughly **2 billion RMB (≈ US$280 million / HK$2.18 billion)**, co-led by IDG Capital and Walden International, at a post-money valuation reported above **US$1.3 billion (about HK$10 billion)**. Around the same time it filed **confidentially for an initial public offering on the Hong Kong Stock Exchange**, working with China International Capital Corporation and UBS, according to multiple financial-news reports. That would make BrainCo one of the first Chinese neurotechnology firms to reach public markets, and a member of Hangzhou's so-called **"Six Little Dragons" (六小龙)** — the city's breakout AI and robotics startups that also include DeepSeek and Unitree. ## Why a headband matters in the BCI race Most of the headline BCI drama is invasive: Neuralink's implants, China's Beinao-1 (北脑一号) speech decoder, surgical electrodes. Those are medically profound but slow to reach ordinary people. BrainCo's quieter achievement is the opposite — a **consumer-grade, non-invasive device that already exists in six figures of units**. That matters because the BCI field has a commercialization gap. High-end implants may restore speech to a locked-in patient, but they will not appear in homes by the million. A wearable EEG headband, whatever its limits, is the version of neurotechnology a shopper can actually buy today. ## What readers should keep in mind The headband does **not** read thoughts. It infers a narrow signal — attention or relaxation state — from scalp electrical activity, which is noisy and easy to game. The classroom episode is the cautionary tale: the same sensor that helps one child focus can become a surveillance tool if deployed carelessly. BrainCo has since reframed Focus as a personal wellness and training aid rather than an institutional monitoring device. ## What readers can do now - **If you buy consumer neurotech**, treat an EEG headband as a feedback trainer, not a medical device. Its value is in making focus or calm measurable, not in diagnosing anything. - **If you follow BCI markets**, watch BrainCo's Hong Kong filing as a test of whether non-invasive consumer BCI can sustain a public-company valuation — the invasive players are still pre-revenue. - **If you build education products**, study the 2019 schools controversy as a privacy case study; attention data on minors is a governance landmine, not a feature. ## Honest limitations Verified facts: BrainCo founded 2015 by Bicheng Han at Harvard Innovation Labs, HQ moved to Hangzhou in 2018 — from Wikipedia and *Securities Times* (证券时报). The 100,000-unit mass-production milestone (January 2022) is reported by *China Daily* based on a company announcement, not an independent audit, and should be read as the company's own claim. The January 2026 financing of ~2 billion RMB (≈ US$280M / HK$2.18B) and confidential HK IPO filing with CICC and UBS are reported by *Securities Times*, Caproasia, Tencent News, and BigGo Finance; valuation is cited between US$1.3B and US$1.8B across sources, so "above US$1.3 billion" is the conservative floor. BrainCo is part of Hangzhou's "Six Little Dragons." The product line (Focus 1 / FocusCalm / FocusZen / Easleep) and the 2019 school-surveillance controversy are documented in Wikipedia and BBC/EDU coverage. The IPO is filed, not completed; no listing date is confirmed. This article contains no investment advice, and analysis is current to 28 September 2026. --- Published by NeuroAI (https://neuroai.site/) — https://neuroai.site/a/na-bci-consumer-focus-headset Free to quote with attribution and a link to the original.